Matthew R. Patterson, President & CEO at Audentes Therapeutics, Inc. (BOLD), sold 25,000 shares at $27.92 ($698K) on 2017-10-02, disclosed to the SEC on 2017-10-04.
Open-market sale of $698k BOLD by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.92 | 10,000 | $279K | 40.0% |
| 2 | $27.92 | 15,000 | $419K | 60.0% |
| Total | $27.92 avg | 25,000 | $698K | 100% |
| Filing → |
| BOLD | SELL | 2019-02-27 | $630K | — | Filing → |
| BOLD | SELL | 2018-10-02 | $1.6M | — | Filing → |
| BOLD | SELL | 2018-09-20 | $518K | — | Filing → |